esophagogastric junction - Globe Thesis

Keyword [esophagogastric junction] Result: 21 - 40 \| Page: 2 of 8
21.	HER2Expression And Significance In Esophagogastric Juction Adenocarcinoma (Siewert Type Ⅱ) In China
22.	The Expression Of EGFR, Her-2and Hsp90α In Esophageal Squamous Cell Carcinoma And Adenocarcinoma Of The Esophagogastric Junction And Its Relationship With Prognostic Significance
23.	Adenocarcinoma Of The Esophagogastric Junction Clinicopathological Characteristics And Analysis Of Prognostic Factors
24.	The Expression Of Foxp3and CD8in Adenocarcinoma Of Esophagogastric Junction (AEG) And Their Clinical And Prognosis Meaning
25.	Short-term Prognosis Of Total Gastrectomy In Advanced Siewert Ⅱ And Ⅲ Adenocarcinoma Of The Esophagogastric Junction(A E G)
26.	A Periodic Report Of The Prospective Clinical Study Of Different Surgical Approaches Affect On Postoperative Quality Of Life And Overall Survival Rates In Ⅱ,ⅢType AEG Patients
27.	Trend Analysis Of Esophagogastric Junction Adenocarcinoma (EGJA)&Evaluation Of Routine Biopsies In Endoscopic Screening For EGJA&Meta Analysis On The Relationship Between Gastroesophageal Reflux And EGJA
28.	Clinical Analysis Of Processing Method For Gastroesophageal Anastomotic In The Resection Of Esophageal And Esophagogastric Junction Cancer
29.	The Safety And Efficiency Of Endoscopic Resection For Submucosal Tumors In The Esophagogastric Junction
30.	Prognosis Of Primary Small Cell Carcinoma Of Esophagogastric Junction Of With Surgical Treatment And Analyses Of Its Influencing Factors
31.	The Prognostic Value Of Tumor-infiltrating Neutrophils In Adenocarcinoma Of The Esophagogastric Junction
32.	Comparison Of Esophageal Acid And Alkaline Exposure Characteristics Between Patients With Adenocarcinoma Of The Esophagogastric Junction After Proximal Gastrectomy And Total Gastrectomy
33.	The Expression Of TAZ In Adenocarcinoma Of The Esophagogastric Junction And Its Clinical Significance
34.	The Prognostic Value Of The Number Of Negative Lymph Nodes In Siewert Type Ⅱ Adenocarcinoma Of The Esophagogastric Junction(AEG) Without Lymphatic Metastasis After Surgery
35.	Progress In The Diagnosis And Therapy Of Esophagogastric Junction Adenocarcinoma
36.	Expression And Significance Of Spartin Protein In Patients With Adenocarcinoma Of Esophagogastric Junction
37.	The Disccusion Of The Therapeutic Effects Of Different Surgical Approaches And Lymphatic Metastasis For Siewert Type Ⅱ Adenocarcinoma Of Esophagogastric Junction
38.	Clinical Comparison Of Laparoscopic And Open Resection Of Adenocarcinoma Of Esophagogastric Junction
39.	Effects Of Transthoracic And Abdominal-transhiatal Resection For The Treatment Of Siewert Type Ⅱ/Ⅲ Adenocarcinoma Of The Esophagogastric Junction: A Meta-analysis
40.	Expression Of MACC1, SIRT1 And MTA3 In EGJA And Its Relationship With Clinical Pathological Factors Related To Tumor Invasion And Prognosis
<<First <Prev Next> Last>> Jump to